About this Research Topic
Similarly, recent investigations also highlighted the relevance of signalling cascade regulation on pharmaco-resistance to treatment with DNA Damage Repair inhibitors in tumours of the CNS. Interestingly, the identification of the role of new and established cell signalling markers may lead to a complete change in the clinical classification of several CNS pathologies, with profound implications for prognosis and therapy.
In this scenario, this Research Topic aims to provide new insights on the actors of cell signalling in the CNS and how their expression and activity couples and dialogues with the epi-genome, ultimately affecting the occurrence and maintenance of several neuronal disorders. We are therefore scouting for groundbreaking studies on new intracellular markers and innovative medical, pharmacological and bio-molecular strategies to deploy for interfering with pathogenic signalling cascades in the CNS.
A Special Note: We would like to dedicate this special issue to the memory of Prof. Matteo Caleo, an exceptional mentor and a friendly colleague. We will always remember his integrity, his kindness, his humility and his smile. We will try to put his lessons into practice, in our research and everyday life.
Keywords: Cell Signalling, Prognostic Biomarkers, New Therapies, Neuro Pharmacoepidemiology, CNS Disorders
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.